Vancomycin HCL 1gm Injectable Powder

The 70594004602 Vancomycin HCL 1gm Injection is a sterile, non-pyrogenic solution used primarily for treating severe bacterial infections. Vancomycin hydrochloride is a glycopeptide antibiotic effective against a wide range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). This 1gm dosage formulation is intended for intravenous administration and is crucial in combating serious infections that are unresponsive to other antibiotics.

Key Features

• Potent Antibiotic: Vancomycin HCL is highly effective against Gram-positive bacteria, including MRSA and other resistant strains.
• Sterile and Non-pyrogenic: The solution is free from contaminants and fever-inducing agents, ensuring safety and efficacy for patient use.
• Broad Spectrum of Activity: Effective in treating a variety of severe infections, such as endocarditis, osteomyelitis, pneumonia, septicemia, and skin infections.

Clinical Applications

• Severe Bacterial Infections: Indicated for the treatment of serious infections caused by susceptible strains of Gram-positive bacteria.
• MRSA Infections: Particularly useful in treating infections caused by methicillin-resistant Staphylococcus aureus.
• Bone and Joint Infections: Effective in managing osteomyelitis and septic arthritis.
• Endocarditis: Used for the treatment of bacterial endocarditis, often in combination with other antibiotics.
• Skin and Soft Tissue Infections: Suitable for severe infections such as cellulitis and abscesses.

Specifications

• Dosage Form: Injection
• Concentration: 1gm Vancomycin Hydrochloride per vial
• Packaging: Single-dose vial
• Administration Route: Intravenous

Usage Instructions

• Preparation: Reconstitute the powder with the appropriate diluent according to the manufacturer's instructions. Ensure the solution is clear and free from particulate matter before administration.
• Dosage and Administration: Dosage should be individualized based on the severity of the infection, patient's weight, renal function, and serum vancomycin concentrations. Administer as an intravenous infusion over at least 60 minutes to reduce the risk of infusion-related reactions.
• Monitoring: Regular monitoring of renal function and serum vancomycin levels is recommended to avoid toxicity and ensure therapeutic effectiveness.